Hepatic and Portal Vein Transection by Vascular Stapler in Open Living Donor Hepatectomy

To enhance donor safety in living donor liver transplantation (LDLT), the use of vascular staplers for the division of the right portal and hepatic veins in patients undergoing right lobe liver donation has been introduced. This study examines the application of vascular staplers in LDLT and assesses the subsequent feasibility and safety outcomes for donors.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatectomy

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Jordan Hospital Amman

Amman, Amman Governorate, 11152, Jordan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients undergoing open living donor hepatectomy
Age ≥ 18 years, ≤ 80 years
Written informed consent

Exclusion criteria

None.

Treatment and study plan

Vascular stapler

Procedure

the utilization of vascular staplers for the division of the right portal and hepatic veins in patients undergoing right lobe liver donation for living donor liver transplantation

Primary outcomes

Post-operative complications (Clavien-Dindo classification)

Time frame: From enrollment to the end of treatment at 6 weeks

Sponsors and collaborators

Lead sponsor

Abdalla Bashir, MD

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2021
Study completion: 2021
First posted: Apr 4, 2025
Registry last updated: Apr 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed